Published by Newswise

$363,000 from Mayday Fund Will Take Research from Lab to Clinic

With new funding from The Mayday Fund, a Saint Louis University researcher will leverage her discovery of a pain pathway to determine if either of two key molecules can be used as biomarkers for pain associated with four debilitating health conditions: chemotherapy-induced peripheral neuropathy (CIPN), endometriosis, interstitial cystitis and vulvodynia.

SLU scientist and principle investigator Daniela Salvemini, Ph.D., will use the $363,000 grant to advance her work to understand pain in order to develop new painkillers.

“It is exciting to reach the moment when you can take your research from the laboratory to the clinic,” said Salvemini, who is professor of pharmacology and physiology at SLU.

Approximately 100 million American adults suffer from chronic pain, costing society around $600 billion annually. This burden will grow with an aging population suffering from diabetes, stroke and cancer.